About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Dallas | 219 Studies

Clinical Trials Colorectal CancerDallas

Colorectal Cancer Clinical Trials in Dallas

Find 219 clinical trials for colorectal cancer near Dallas, Texas. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Dallas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 181-200 of 219 trials

Active not recruitingFirst in Human Study of TORL-3-600 in Participants With Advanced CancerThis first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-3-600 in patients with advanced cancerNCT05948826·Fullerton, California and 8 others RecruitingSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryInternational registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool…NCT03452774·Birmingham, Alabama and 67 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedA Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid TumorsThis study will evaluate the efficacy and safety of alectinib in participants with Anaplastic Lymphoma Kinase (ALK)-positive locally advanced or metastatic solid tumors other than…NCT04644315·Culver City, California and 28 others

RecruitingA Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsThis clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors.NCT04657068·Birmingham, Alabama and 87 others

RecruitingTesting Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP TrialThis phase III trial compares hepatic arterial infusion (HAI) (pump chemotherapy) in addition to standard of care chemotherapy versus standard of care chemotherapy alone in…NCT05863195·Birmingham, Alabama and 61 others

CompletedA Study in Second Line Metastatic Colorectal CancerThe purpose of this study is to compare overall survival in participants with metastatic colorectal cancer treated with either ramucirumab and FOLFIRI or placebo and FOLFIRI.NCT01183780·Sedona, Arizona and 212 others

CompletedPROSPR Project 1: Identifying and Tracking Personalized CRC Screening Regimens for Patients in Clinical SettingsThe overall goal of the Parkland-UT Southwestern Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) Center is to optimize colon cancer screening…NCT03705897·Dallas, Texas

UnknownComparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00008281·Huntsville, Alabama and 133 others

UnknownStudy of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesStudy of NGM707 as Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesNCT04913337·Los Angeles, California and 26 others

TerminatedRandomized Phase II Adjuvant Chemotherapy ± FANG™ in Colorectal Carcinoma With Liver MetastasesPreliminary studies with a variety of vaccines suggest target accessibility (potential immunogenicity) in a variety of solid tumors to immune directed approaches.NCT01505166·Dallas, Texas

TerminatedSavolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal CancerThis phase II trial studies how well savolitinib works in treating patients with MET amplified colorectal cancer that has spread to other places in the body (metastatic) or cannot…NCT03592641·Los Angeles, California and 32 others

CompletedPatients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard TherapyThis is a randomized, double-blind, placebo-controlled multi-center phase III study to evaluate efficacy and safety of regorafenib in patients with metastatic colorectal cancer…NCT01103323·Beverly Hills, California and 170 others

RecruitingPhase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid TumorsPhase I Study, a master protocol to investigate TCR-Engineered T cells recognizing KRAS mutations in adult subjects with Unresectable, Advanced, and/or Metastatic Solid Tumors.NCT06218914·Duarte, California and 17 others

CompletedStudy of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) SubjectsTo determine if sorafenib when added to chemotherapy will slow disease progression more than chemotherapy alone in patients previously untreated for metastatic colorectal cancer.NCT00865709·Wichita, Kansas and 115 others

CompletedA Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal CancerThis is an open-label, non-controlled study conducted in two parts - Part A (dose escalation) followed by Part B (dose expansion).NCT03819387·Beverly Hills, California and 8 others

TerminatedSurufatinib in Combination With Tislelizumab in Subjects With Advanced Solid TumorsThis open-label, phase Ib/II study of surufatinib in combination with tislelizumab will evaluate the safety, tolerability, PK and efficacy in patients with advanced solid tumors.NCT04579757·Tucson, Arizona and 17 others

TerminatedA Phase III Study of Xilonix in Patients With Advanced Colorectal CancerThe purpose of this study is to determine if the True Human Monoclonal antibody Xilonix (MABp1) can prolong the life of colorectal carcinoma patients that are refractory to…NCT01767857·Birmingham, Alabama and 112 others

CompletedSafety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the LiverThis study is an open-label study. It has two stages.NCT00149396·San Diego, California and 4 others

RecruitingA Phase 1 Study of JMT108 in Participants With Advanced Solid TumorsThe goal of this clinical trial is to test JMT108, a type of drug called a bispecific antibody in adult patients with locally advanced or metastatic solid tumors.NCT07317505·Huntersville, North Carolina and 2 others

TerminatedA Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal CancerThe study will combine a new investigational drug with standard anti-cancer drugs for the treatment of advanced colorectal cancer.NCT00040391·Little Rock, Arkansas and 27 others

PreviousPage 10 of 11Next

Other Conditions in Dallas

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma